Related Experiment Videos
Neutrophil surface markers in patients with acute leukemia
Blood
|February 1, 1981
Summary
Neutrophil complement C3b receptors are reduced in acute leukemia patients at diagnosis and relapse, but normalize during remission. Fc receptors and C3d receptors remain unaffected throughout the disease stages.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Neutrophils play a critical role in the immune response.
- Leukemia significantly impacts immune cell function.
- Complement and Fc receptors on neutrophils are crucial for immune surveillance and pathogen clearance.
Purpose of the Study:
- To investigate the expression of complement and Fc receptors on neutrophils in acute leukemia patients.
- To determine how receptor levels change during different stages of leukemia: diagnosis, relapse, and remission.
Main Methods:
- Flow cytometry was used to quantify Fc receptors (Fc-H, Fc-R) and complement receptors (C3b, C3d) on neutrophils.
- Patient samples were analyzed at diagnosis, relapse, and remission phases of acute leukemia.
Main Results:
- Fc receptors (Fc-H, Fc-R) and the C3d receptor remained normal across all disease stages.
- The C3b receptor was significantly reduced on neutrophils at diagnosis and relapse.
- C3b receptor levels normalized when patients achieved remission.
Conclusions:
- The C3b receptor is specifically downregulated on neutrophils during active acute leukemia (diagnosis and relapse).
- Neutrophil C3b receptor expression is a potential biomarker for monitoring leukemia status.
- Immune dysregulation in leukemia involves specific alterations in complement receptor expression.